Severe drug eruption induced by ozanimod hydrochloride capsules: clinical analysis of a case

Juan Du¹, Qiuhe Song¹, Meijun Wu^1*

¹Affiliated Hospital of Jiujiang College, Jiujiang, Jiangxi, 332000

*Correspondence:

Meijun Wu; Email: 18779295286@163.com

Abstract

Ozanimod is an oral sphingosine-1-phosphate receptor modulator approved for the induction and maintenance of remission in multiple sclerosis and ulcerative colitis. Although generally well tolerated, several reports have described the occurrence of malignancies following ozanimod therapy. We now report a rare case of a severe drug eruption that developed one week after initiation of ozanimod therapy.

Keywords: severe drug eruption, oral sphingosine-1-phosphate receptor modulator, clinical analysis